CatSci Ltd, an award-winning innovation partner for medicines development, will be attending BioTrinity London 2023. Taking place on 25th – 26th April 2023, BioTrinity encourages growth and engagement in the life sciences industry.
Our CEO, Dr Ross Burn, and our Head of Customer Acquisition, Jenn Clark, will be attending this established London conference. They are looking forward to engaging with the industry and exploring how CatSci can support your drug development needs.
To book a meeting with Ross and Jenn, please get in touch here.